Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 5896 to 5910 of 7615 results

  1. The committee recommended that further research is needed to better understand the natural history of low-volume cervical intraepithelial neoplasia (CIN) 2 lesions.

    Recommendation ID DG32/4 Question The committee recommended that further research is needed to better understand the natural history of

  2. The committee recommends collecting further data on clinical outcomes such as time to healing, and incorrect use of compression and its associated adverse consequences when possible.

    Recommendation ID DG52/3 Question The committee recommends collecting further data on clinical outcomes such as time to healing, and incorrect

  3. The committee recommends collecting further data on the impact of the automated devices on time to treatment for people with leg ulcers to reduce uncertainty in the economic modelling.

    Recommendation ID DG52/2 Question The committee recommends collecting further data on the impact of the automated devices on time to treatment

  4. The committee recommends more research on diagnostic accuracy in people with leg ulcers. The following considerations should be made when doing this research:

    Recommendation ID DG52/1 Question The committee recommends more research on diagnostic accuracy in people with leg ulcers. The following

  5. The Committee recommends that a study estimating utility values using directly observed health-related quality of life values (such as EQ 5D scores) in patients with myelodysplastic syndromes, chronic myelomonocytic leukaemia or acute myeloid leukaemia is conducted.

    Recommendation ID TA218/1 Question The Committee recommends that a study estimating utility values using directly observed health-related

  6. The consequences and costs of poor transition:- What are the consequences and the costs of young people with ongoing needs not making a transition into adult services, or being poorly supported through the process?

    Recommendation ID NG43/4 Question The consequences and costs of poor transition:- What are the consequences and the costs of young people

  7. Provider incentives: What is the effectiveness and acceptability of giving incentives to providers to increase immunisation rates in the UK?

    Recommendation ID NG218/09 Question Provider incentives: What is the effectiveness and acceptability of giving incentives to providers

  8. Psychological treatments: What is the cost effectiveness of providing tailored psychological treatments for people with epilepsy?

    Recommendation ID NG217/05 Question Psychological treatments: What is the cost effectiveness of providing tailored psychological treatments

  9. Incentives aimed at individuals, family members and carers: What is the effectiveness and acceptability of incentives to increase uptake of routine vaccines in the UK?

    Recommendation ID NG218/02 Question Incentives aimed at individuals, family members and carers: What is the effectiveness and acceptability

  10. Staff training:- What is the cost effectiveness of using a dementia-specific addition to the Care Certificate for community staff, including dementia-specific elements on managing anxiety, communication, nutritional status and personal care?

    Recommendation ID NG97/2 Question Staff training:- What is the cost effectiveness of using a dementia-specific addition to the Care Certificate

  11. Ways of providing advocacy services: What is the effectiveness and acceptability of providing advocacy through different approaches?

    Recommendation ID NG227/01 Question Ways of providing advocacy services: What is the effectiveness and acceptability of providing advocacy

  12. Quasi-mandation of vaccinations: What is the effectiveness and acceptability of quasi-mandation to increase vaccine uptake of routine vaccines?

    Recommendation ID NG218/03 Question Quasi-mandation of vaccinations: What is the effectiveness and acceptability of quasi-mandation to

  13. Cost utility:- What is the cost utility of increasing the offer or uptake of HIV testing in different settings, for different types of tests, using different strategies (for example opt-in or opt-out approaches) and in areas and groups with different background prevalence?

    Recommendation ID NG60/5 Question Cost utility:- What is the cost utility of increasing the offer or uptake of HIV testing in different